4911 Stock Overview
G&E Herbal Biotechnology Co., Ltd., a biotechnology company, focuses on the development and commercialization of novel botanical extraction technology and products in Taiwan.
G&E Herbal Biotechnology Co., Ltd. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$62.10|
|52 Week High||NT$72.20|
|52 Week Low||NT$22.50|
|1 Month Change||14.15%|
|3 Month Change||8.76%|
|1 Year Change||155.03%|
|3 Year Change||41.62%|
|5 Year Change||30.60%|
|Change since IPO||16.38%|
Recent News & Updates
G&E Herbal Biotechnology (GTSM:4911) Is In A Strong Position To Grow Its Business
We can readily understand why investors are attracted to unprofitable companies. For example, although...
|4911||TW Personal Products||TW Market|
Return vs Industry: 4911 exceeded the TW Personal Products industry which returned -6.3% over the past year.
Return vs Market: 4911 exceeded the TW Market which returned -19% over the past year.
|4911 Average Weekly Movement||12.4%|
|Personal Products Industry Average Movement||5.8%|
|Market Average Movement||5.1%|
|10% most volatile stocks in TW Market||8.3%|
|10% least volatile stocks in TW Market||2.5%|
Stable Share Price: 4911 is more volatile than 90% of TW stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: 4911's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
G&E Herbal Biotechnology Co., Ltd., a biotechnology company, focuses on the development and commercialization of novel botanical extraction technology and products in Taiwan. It offers hepato protective agent capsules for the treatment of chronic liver inflammation, cirrhosis, hepatitis, and other liver diseases; botanical anti-aging cosmetic products, such as foam cleanser, botanical extract toner, moisture conditioning cream, and whitening clear cream; and SR-100 skin repair gel. The company also provides botanical healthcare products comprising ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules; and adult products.
G&E Herbal Biotechnology Co., Ltd. Fundamentals Summary
|4911 fundamental statistics|
Is 4911 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|4911 income statement (TTM)|
|Cost of Revenue||NT$20.60m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.36|
|Net Profit Margin||-71.80%|
How did 4911 perform over the long term?See historical performance and comparison